These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12505193)

  • 1. Components with potential immunosuppressive activity in lipopolysaccharide of laboratory Pseudomonas aeruginosa strains.
    Vikström EV
    Immunol Lett; 2003 Jan; 85(1):29-33. PubMed ID: 12505193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunosuppressive activity of chemically modified lipopolysaccharide of Shigella sonnei.
    Vikström EV
    Immunol Lett; 2002 Jan; 80(1):15-9. PubMed ID: 11716960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunosuppressive components of extracellular polysaccharide from Pseudomonas aeruginosa clinical strains].
    Borisova EV
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (6):35-8. PubMed ID: 11210632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of the structural components of bacterial lipopolysaccharide in its inductive immunosuppressive activity].
    Borisova EV
    Mikrobiol Z; 1999; 61(6):36-41. PubMed ID: 10707531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of the structural parts of bacterial lipopolysaccharide in its direct immunosuppressive activity].
    Borisova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (2):22-5. PubMed ID: 10356729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The immunosuppressive activity of filtrates of the culture broth from nonvirulent salmonellae].
    Molozhavaia OS; Borisova EV; Borisov VA
    Mikrobiol Z; 1997; 59(2):73-8. PubMed ID: 9221061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The inductive immunosuppressive activity of the lipopolysaccharide from Shigella sonnei R forms].
    Borisova EV
    Mikrobiol Z; 1998; 60(3):63-9. PubMed ID: 9785801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunosuppressive action of lipopolysaccharide S- and R-forms of Salmonella and the role of lipid A].
    Borisova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (6):20-3. PubMed ID: 9949494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The inductive immunosuppressive activity of the nonspecific lipopolysaccharide fraction of virulent Shigella sonnei].
    Borisova EV; Borisov VA
    Mikrobiol Z; 1997; 59(1):77-81. PubMed ID: 9172868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunosuppressive components of extracellular lipopolysaccharide highly virulent strain Salmonella typhimurium 1468].
    Molozhavaia OS; Borisova EV
    Mikrobiol Z; 2002; 64(3):75-80. PubMed ID: 12190039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The immunosuppressive action of different fractions of Salmonella typhimurium lipopolysaccharide].
    Borisova EV; Bondarenko VM; Molozhavaia OS; Borisov VA
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (5):120-3. PubMed ID: 9432837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The inhibition of the cellular immune response by Pseudomonas aeruginosa extracts].
    Borisova VA; Furtat IM; Zgonnik VV; Borisova EV; Lolo AA; Shilina IuV
    Mikrobiol Zh (1978); 1993; 55(2):82-7. PubMed ID: 8497204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The immunomodulating properties of the filtrates of Klebsiella culture broth and the nature of the immunomodulating factor].
    Borisova EV; Polishchuk EI; Sel'nikova OP; Mishina LN; Borisov VA
    Mikrobiol Z; 1996; 58(6):55-62. PubMed ID: 9064073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity.
    Pier GB
    Int J Med Microbiol; 2007 Sep; 297(5):277-95. PubMed ID: 17466590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
    Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R
    J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomonas aeruginosa antigens as potential vaccines.
    Stanislavsky ES; Lam JS
    FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent cystic fibrosis isolate Pseudomonas aeruginosa strain RP73 exhibits an under-acylated LPS structure responsible of its low inflammatory activity.
    Di Lorenzo F; Silipo A; Bianconi I; Lore' NI; Scamporrino A; Sturiale L; Garozzo D; Lanzetta R; Parrilli M; Bragonzi A; Molinaro A
    Mol Immunol; 2015 Feb; 63(2):166-75. PubMed ID: 24856407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of polyagglutinating and surface antigens in Pseudomonas aeruginosa.
    Meadow PM; Rowe PS; Wells PL
    J Gen Microbiol; 1984 Mar; 130(3):631-44. PubMed ID: 6427402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rfb locus from Pseudomonas aeruginosa strain PA103 promotes the expression of O antigen by both LPS-rough and LPS-smooth isolates from cystic fibrosis patients.
    Evans DJ; Pier GB; Coyne MJ; Goldberg JB
    Mol Microbiol; 1994 Aug; 13(3):427-34. PubMed ID: 7527892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditioned immunosuppressive effect of cyclophosphamide on delayed-type hypersensitivity response and a preliminary analysis of its mechanism.
    Mei L; Li L; Li Y; Deng Y; Sun C; Ding G; Fan S
    Neuroimmunomodulation; 2000; 8(1):45-50. PubMed ID: 10859488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.